Teva Pharmaceutical Industries Ltd (TEVA)

CIK 818686 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Teva Pharmaceutical Industries Ltd.

Recent SEC filings

FiledFormAccession number
Nov 5, 20261440001973379-26-000362
Nov 4, 20261440001973379-26-000356
Nov 3, 202610-Q0000818686-26-000006
Nov 3, 20268-K0001171843-26-007054
Nov 2, 2026SCHEDULE 13G/A0001178913-26-004925
Oct 29, 20268-K0001193125-26-438019
Oct 8, 202630001193125-26-417902
Sep 22, 202640001193125-26-398105
Sep 22, 202640001193125-26-397959
Sep 21, 20261440001973379-26-000342
Sep 18, 20261440000919574-26-006400
Sep 16, 20268-K0001193125-26-393116
Sep 14, 20268-A12B/A0001193125-26-390559
Sep 14, 20268-K0001193125-26-390562
Sep 14, 202625-NSE0000876661-26-000744
Sep 11, 20268-K0001193125-26-389264
Sep 11, 2026424B50001193125-26-389382
Sep 10, 2026FWP0001193125-26-387112
Sep 10, 2026FWP0001193125-26-387100
Sep 8, 2026424B50001193125-26-384343
Sep 3, 20268-K0001193125-26-381879
Sep 3, 20268-K0001193125-26-381899
Aug 25, 202640001193125-26-365107
Aug 25, 202640001193125-26-365116
Aug 19, 202640001193125-26-356853